Literature DB >> 21746909

Tumor suppressor p53 regulates bile acid homeostasis via small heterodimer partner.

Dae-Hwan Kim1, Jae W Lee.   

Abstract

Metabolic changes in cancer have been observed for almost a century. The mechanisms underlying these changes have begun to emerge from the recent studies implicating the tumor suppressor p53 in multiple metabolic pathways. The ability of p53 to regulate metabolism may also play important roles in the physiology of normal cells and organs. Here we demonstrate that p53 lowers bile acid (BA) levels under both normal and stressed conditions primarily through up-regulating expression of small heterodimer partner, a critical inhibitor of BA synthesis. Our results uncover a unique metabolic regulatory axis that unexpectedly couples p53 to BA homeostasis. Our results also warrant future studies to investigate a possible role of this axis in the tumor suppression by p53, because excessive quantities of BAs are cytotoxic and can cause liver damage and promote gastrointestinal cancers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21746909      PMCID: PMC3145715          DOI: 10.1073/pnas.1019678108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.

Authors:  Jeongkyung Lee; Dae-Hwan Kim; Seunghee Lee; Qi-Heng Yang; Dong Kee Lee; Soo-Kyung Lee; Robert G Roeder; Jae W Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

2.  A crucial role for adipose tissue p53 in the regulation of insulin resistance.

Authors:  Tohru Minamino; Masayuki Orimo; Ippei Shimizu; Takeshige Kunieda; Masataka Yokoyama; Takashi Ito; Aika Nojima; Akira Nabetani; Yuichi Oike; Hisahiro Matsubara; Fuyuki Ishikawa; Issei Komuro
Journal:  Nat Med       Date:  2009-08-30       Impact factor: 53.440

3.  Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription.

Authors:  Wei-Dong Chen; Yan-Dong Wang; Lisheng Zhang; Steven Shiah; Meihua Wang; Fan Yang; Donna Yu; Barry M Forman; Wendong Huang
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

4.  A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.

Authors:  Jiyoung Lee; Amruta Padhye; Abhilasha Sharma; Guisheng Song; Ji Miao; Yin-Yuan Mo; Li Wang; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

5.  Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.

Authors:  Rengasamy R M Maran; Ann Thomas; Megan Roth; Zhonghua Sheng; Noriko Esterly; David Pinson; Xin Gao; Yawei Zhang; Vadivel Ganapathy; Frank J Gonzalez; Grace L Guo
Journal:  J Pharmacol Exp Ther       Date:  2008-11-03       Impact factor: 4.030

6.  Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation.

Authors:  Ji Miao; Zhen Xiao; Deepthi Kanamaluru; Gyesik Min; Peter M Yau; Timothy D Veenstra; Ewa Ellis; Steve Strom; Kelly Suino-Powell; H Eric Xu; Jongsook Kim Kemper
Journal:  Genes Dev       Date:  2009-04-15       Impact factor: 11.361

Review 7.  p53 and metabolism.

Authors:  Karen H Vousden; Kevin M Ryan
Journal:  Nat Rev Cancer       Date:  2009-09-17       Impact factor: 60.716

Review 8.  Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense.

Authors:  Ivan A Olovnikov; Julia E Kravchenko; Peter M Chumakov
Journal:  Semin Cancer Biol       Date:  2008-12-03       Impact factor: 15.707

Review 9.  Bile-acid-induced cell injury and protection.

Authors:  Maria-J Perez; Oscar Briz
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

10.  ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.

Authors:  Dae-Hwan Kim; Jeongkyung Lee; Bora Lee; Jae W Lee
Journal:  Mol Endocrinol       Date:  2009-06-25
View more
  11 in total

1.  p53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice.

Authors:  Pan Chen; Dongshun Li; Yixin Chen; Jiahong Sun; Kaili Fu; Lihuan Guan; Huizhen Zhang; Yiming Jiang; Xi Li; Xuezhen Zeng; Xiao Chen; Min Huang; Huichang Bi
Journal:  Br J Pharmacol       Date:  2017-10-22       Impact factor: 8.739

2.  Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice.

Authors:  Dae-Hwan Kim; Jennifer Chiyeon Rhee; Sujeong Yeo; Rongkun Shen; Soo-Kyung Lee; Jae W Lee; Seunghee Lee
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

3.  Requirement for MLL3 in p53 regulation of hepatic expression of small heterodimer partner and bile acid homeostasis.

Authors:  Dae-Hwan Kim; Juhee Kim; Jae W Lee
Journal:  Mol Endocrinol       Date:  2011-10-27

4.  Sex-specific hepatic lipid and bile acid metabolism alterations in Fancd2-deficient mice following dietary challenge.

Authors:  Elizabeth S Moore; Erin K Daugherity; David I Karambizi; Bethany P Cummings; Erica Behling-Kelly; Deanna M W Schaefer; Teresa L Southard; Joseph W McFadden; Robert S Weiss
Journal:  J Biol Chem       Date:  2019-08-21       Impact factor: 5.157

5.  Cross-regulation of protein stability by p53 and nuclear receptor SHP.

Authors:  Zhihong Yang; Yuxia Zhang; Jongsook Kim Kemper; Li Wang
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

6.  The complexity of p53-mediated metabolic regulation in tumor suppression.

Authors:  Yanqing Liu; Wei Gu
Journal:  Semin Cancer Biol       Date:  2021-03-27       Impact factor: 17.012

7.  Anomalies in network bridges involved in bile Acid metabolism predict outcomes of colorectal cancer patients.

Authors:  Sunjae Lee; KiYoung Lee; Seyeol Yoon; Jae W Lee; Doheon Lee
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

8.  Hepatic Vps33b deficiency aggravates cholic acid-induced cholestatic liver injury in male mice.

Authors:  Kai-Li Fu; Pan Chen; Yan-Ying Zhou; Yi-Ming Jiang; Yue Gao; Hui-Zhen Zhang; Li-Huan Guan; Cong-Hui Wang; Jun-Ling Liu; Min Huang; Hui-Chang Bi
Journal:  Acta Pharmacol Sin       Date:  2021-07-12       Impact factor: 6.150

9.  Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).

Authors:  Yanyong Xu; Yingdong Zhu; Shuwei Hu; Yang Xu; Diane Stroup; Xiaoli Pan; Fathima Cassim Bawa; Shaoru Chen; Raja Gopoju; Liya Yin; Yanqiao Zhang
Journal:  Hepatology       Date:  2021-05-14       Impact factor: 17.298

10.  The anti-hypercholesterolemic effect of low p53 expression protects vascular endothelial function in mice.

Authors:  Francois Leblond; Steve Poirier; Carol Yu; Natacha Duquette; Gaetan Mayer; Eric Thorin
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.